very good quote

不愿作医药类股，不是翻倍，就是腰斩. The difference in this market now is that we see lots of 腰斩, but no 翻倍. Just played AMLN option and got nothing out of it because the stock basically did nothing after FDA approval news. Now, the ELN disater. Fortunately I made out a lot from the option on this one, so it eased the pain a little. But this will be my last drug play for a while with serious money.